Filing Details
- Accession Number:
- 0001138639-18-000037
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-02-23 17:05:21
- Reporting Period:
- 2018-02-21
- Accepted Time:
- 2018-02-23 17:05:21
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1138639 | Infinera Corp | INFN | Telephone & Telegraph Apparatus (3661) | 770560433 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1399122 | F David Welch | C/O Infinera Corporation 140 Caspian Court Sunnyvale CA 94089 | Chief Strategy & Tech. Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2018-02-21 | 35,407 | $10.01 | 564,351 | No | 4 | S | Indirect | See Footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See Footnote |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 292,293 | Indirect | See Footnote |
Common Stock | 528,150 | Indirect | See Footnote |
Common Stock | 140,000 | Indirect | See Footnote |
Common Stock | 2,500 | Indirect | See Footnote |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (Right to Buy) | $7.11 | 2019-02-10 | 100,000 | 100,000 | Direct | |
Common Stock | Employee Stock Option (Right to Buy) | $7.45 | 2019-08-10 | 150,000 | 150,000 | Direct | |
Common Stock | Employee Stock Option (Right to Buy) | $8.58 | 2021-02-10 | 20,250 | 20,250 | Direct | |
Common Stock | Employee Stock Option (Right to Buy) | $8.58 | 2021-02-10 | 60,750 | 60,750 | Direct | |
Common Stock | Employee Stock Option (Right to Buy) | $8.58 | 2021-02-10 | 39,465 | 39,465 | Direct | |
Common Stock | Employee Stock Option (Right to Buy) | $8.58 | 2021-02-10 | 41,535 | 41,535 | Direct | |
Common Stock | Restricted Stock Units | $0.00 | 9,590 | 9,590 | Direct | ||
Common Stock | Restricted Stock Units | $0.00 | 14,385 | 14,385 | Direct | ||
Common Stock | Restricted Stock Units | $0.00 | 65,137 | 65,137 | Direct | ||
Common Stock | Restricted Stock Units | $0.00 | 114,831 | 114,831 | Direct | ||
Common Stock | Restricted Stock Units | $0.00 | 68,750 | 68,750 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2019-02-10 | 100,000 | 100,000 | Direct |
2019-08-10 | 150,000 | 150,000 | Direct |
2021-02-10 | 20,250 | 20,250 | Direct |
2021-02-10 | 60,750 | 60,750 | Direct |
2021-02-10 | 39,465 | 39,465 | Direct |
2021-02-10 | 41,535 | 41,535 | Direct |
9,590 | 9,590 | Direct | |
14,385 | 14,385 | Direct | |
65,137 | 65,137 | Direct | |
114,831 | 114,831 | Direct | |
68,750 | 68,750 | Direct |
Footnotes
- This sale was made pursuant to a Rule 10b5-1 Trading Plan for The Welch Family Trust u/a dtd 04/03/1996 ("The Welch Family Trust").
- This price represents the weighted average sale price of the shares sold by The Welch Family Trust in multiple transactions at prices ranging from $10.00 to $10.04 per share. Upon request by the staff of the Securities and Exchange Commission, Infinera Corporation (the "Company") or a security holder of the Company, Dr. Welch will provide full information regarding the number of shares sold at each separate price.
- These shares are held directly by The Welch Family Trust, for which Dr. Welch is a trustee.
- These shares are held directly by LRFA, LLC, for which Dr. Welch is the sole managing member.
- These shares are held directly by The Welch Family Heritage Trust I u/I dated 9/24/01, for which Dr. Welch is a trustee.
- These shares are held directly by The Welch Group, L.P., for which Dr. Welch is a general partner.
- These shares are held directly by Dr. Welch as a trustee for his children. Dr. Welch disclaims beneficial ownership of the shares held in trust for his children, and this report shall not be deemed an admission that Dr. Welch is the beneficial owner of the shares held in trust for his children for purposes of Section 16 or for any other purpose.
- This option is fully-vested.
- Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Company's common stock.
- These RSUs vest in three annual installments beginning on May 5, 2016.
- These RSUs vest in full on May 5, 2018.
- These RSUs vest in four annual installments beginning on May 5, 2017.
- These RSUs vest in four annual installments beginning on May 5, 2018.
- These RSUs vest in four annual installments beginning on May 5, 2019.